- Contract Research Service
Myrio is a privately-owned company based in Melbourne, Australia.
Our Retained Display (ReD) discovery platform specializes in identifying antibodies that target peptide MHC complexes – targeting some of the most difficult oncology targets.
We engage in broad collaborations with both local and international teams to advance antibody discovery efforts.
